B. Mccolgan

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 361 citations

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell et al. · Gastroenterology · 2018 · 355 citations

Hepatology, Liver Physiology, Immunology +10

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

Rohit Loomba, Zeid Kayali, Mazen Noureddin et al. · Gastroenterology · 2018 · 329 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis

Eric Lawitz, Angie Coste, Fred Poordad et al. · Clinical Gastroenterology and Hepatology · 2018 · 213 citations

Metabolic Syndrome, Metabolic Associated Steatohepatitis, Hepatology +12

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

Andrew J. Muir, Cynthia Levy, Harry L.A. Janssen et al. · Hepatology · 2018 · 189 citations